- Advanced search
- Guide to IMMUNOPHARMACOLOGY Portal
Molecular properties generated using the CDK
|Compound class||Synthetic organic|
|example 189 [WO2013028818A1] | gusacitinib (proposed INN)|
|ASN002 is an orally bioavailable dual spleen tyrosine kinase (SYK)/pan Janus kinase (JAK) inhibitor that is being developed by Asana BioSciences. It is being evaluated for clinical efficacy in inflammatory and oncology settings. The chemical structure shown here matches the IUPAC name and CAS number submitted to the WHO for the INN gusacitinib. Not to be confused with Ascend Biopharmaceuticals immuno-oncology lead ASN-002, which is an engineered virus that expresses IFN-γ.
ASN002 is one of the chemical structures (example 189) claimed in Asana Biosciences' patent WO2013028818A1 .
|GtoPdb PubChem SID||374883887|
|Search Google for chemical match using the InChIKey||NLFLXLJXEIUQDL-UHFFFAOYSA-N|
|Search Google for chemicals with the same backbone||NLFLXLJXEIUQDL|
|Search UniChem for chemical match using the InChIKey||NLFLXLJXEIUQDL-UHFFFAOYSA-N|
|Search UniChem for chemicals with the same backbone||NLFLXLJXEIUQDL|